|
Press and Media
Join us at BioMedical Asia 2009 for months of highly targeted exposure. Capitalise on this ideal platform to market your publication and form strategic relationships through networking at the BioMedical series of conferences!
-
Brand your publication with an event that the industry believes in
-
Fully capitalise on our integrated marketing campaign
-
Increased customer contact and business opportunities
-
Wider exposure to International organisations
-
A unique opportunity to give clients “hands on” experience with your products / services
-
Gain exclusive interviews with the region’s movers and shakers
-
Avail yourself of invaluable editorial & feature content at the conference
For more information on how your title can be profiled as the industry's leading publication across 6 great industry-focused conferences, please contact:
Ruby Liu
ruby.liu@terrapinn.com
These are the partners who have already come on board BioMedical Asia 2009
Endorsers:
The Bioindustry Association of Korea (BAK) was founded in 1991 with an expectation to be a key institution by developing the various programs aiming at the strong competitive country in the biotechnology industry.
Since its inauguration, BAK has been operating various programs such as
- Development of bioindustry platforms
- International cooperation
- Survey and Publication
- Submission of the policies to government and services to members
BAK wishes to remain as a key organization contributing to the country to keep the sustainable development of the bioindustry by its faithful services and implementation of the given missions.
 The Hungarian Biotechnology Association (HBA) was established by Hungary’s leading life science companies in 2003. The main objective of the organization is to create an alliance that unites the voice and interests of companies, researchers, academic institutions and related organizations to provide them with shared services, advocacy, and to help them find success and opportunities in the field of life sciences. Through its various national and international projects, the organization also intends to improve and shape the public understanding, and promote the safe and ethical use of biotechnological innovations as well as educate the future generation of biotechnology managers. Furthermore, the Association’s goals include winning governmental support for the biotechnology sector – in order to reach this, the organization prepares documents and carries out harmonized lobbying activities. The Association also represents its members at major international conferences and exhibitions where it displays company posters, brochures and flyers. At its website, HBA includes information about its members and offers an opportunity to post press releases and company profiles.
HBA membership is open to national and international companies, research institutions, universities and related organizations. Our members include various life science companies, law and consultant firms, and non-profit organizations.
Supporting events:
 CALAsia is the only international forum to connect key life science decision-makers from California and Asia Pacific together to identify, explore, and further trans-Pacific business endeavors.
Representatives of the international life science community, including established and emerging companies, pharmaceutical companies, investors, academic and research institutions and delegations representing several Asia Pacific countries will meet face-to-face in February of 2009, when BIOCOM hosts this global conference.
The CALAsia conference will bring together the leading life science regions spanning Asia Pacific with the primary focus centered on partnering ~ bringing together the Asia Pacific and California regions by providing a forum for unprecedented partnering and one-on-one meetings to link east and west.
CALAsia will educate participants from both sides of the pacific about the opportunities and challenges facing the life science industry in each region in order to better take advantage of the strengths of each.
The Healthcare Industry Forum (HIF), started from 1997, has been held for 11 years. The HIF, having been striving to reflect the international hotspots and needs in a unique angle of view, to lead the development of Chinese biopharmaceutical industry, has become the vane for the industry development and been made reference to the strategy for future development of Chinese pharmaceutical enterprises. By far, the HIF has invited about 510 indutrial and academic authorities from home and abroad to present keynote speeches and held 114 communicative professional roundtables and workshops. Over the 12 years, HIF was set as the platform for communication and collaborations between entrepreneurs, scientist, investors and official home and abroad. The thoughts and opinions emerged on the HIFs witnessed the development of the Chinese biopharmaceutical industry, which makes HIF become an important windows for Chinese biopharmaceutical industry to look into the global market.
The 12th HIF will be held during October 22nd to 24th at the Beijing International Convention Center. The Forum will be under the theme of “One World One Standard”. Join us at 12th HIF and see China right after the Olympics! Please click http://www.hif.com.cn/en/
Official broadcaster:
Official business paper:
The Wall Street Journal Asia is the leader in global business news for Asia. Since 1976, it has provided indispensable news and analysis of regional and global business developments for an influential pan-Asian audience of corporate and government decision-makers. The Wall Street Journal Asia has been voted the most "important business reading" among international daily newspapers in Asia in every ABRS study since the survey's inception in 1985.
The Wall Street Journal's China staff won a Pulitzer Prize in 2007 for coverage of the consequences of the nation's rapid growth. The Wall Street Journal Asia and Far Eastern Economic Review, both of which are published by Dow Jones & Co., won a combined eight awards in the 2007 Society of Publishers in Asia awards for Editorial Excellence. In 2008, The Wall Street Journal Asia received two Awards for Excellence in page design from the Society for News Design.
Edited and published in Hong Kong, The Wall Street Journal Asia is printed in nine Asian cities-Bangkok, Hong Kong, Jakarta, Kuala Lumpur, Manila, Seoul, Singapore, Taipei and Tokyo-and distributed throughout the Asia Pacific region. More than 75% of its subscribers are Asian.
The Wall Street Journal Asia also can be found at The Wall Street Journal Online at WSJ.com, the largest paid subscription news site on the Web. The Wall Street Journal Asia also is published online in Chinese at Chinese.wsj.com.
Media partners:
 The 2008 – 2009 ARCS Australia Professional Development Brochure showcases the 38 courses ARCS Australia offers professionals working in the development of therapeutic drugs and devices. Incorporated in the brochure you will also see detailed Professional Development Pathways for people working in either Clinical Research or Regulatory Affairs.
The Clinical Research Pathway includes 20 educational events taking a clinical research professional from entry level/clinical site monitoring through to clinical project management/project leadership. This year also sees the introduction of a pathway for those working at investigational research sites.
The Regulatory Affairs Professional Development Pathway is made up of 21 different educational events. It is an approach which integrates ARCS workshops, industry updates and education driven by the TGA and takes regulatory affairs professionals from entry level through to advanced topics.
 World Scientific Publishing publishes Asia Pacific Biotech News (APBN), the first and only fortnightly report on pharmaceutical, medical, agricultural and environmental sciences in Asia Pacific. APBN is a premium magazine providing industry professionals and experts with breaking news and updates on biotechnology in Asia Pacific. With its rich contents accompanied by insightful and in-depth reports, APBN is widely read by professionals and researchers in the biotechnology sector around the world. Our magazine has a wide reach to the life sciences and biotech community and is present in major conferences in the region. Please visit www.asiabiotech.com
 BioPharm International integrates the science and business of biopharmaceutical research and development, and production/manufacturing. The magazine provides peer-reviewed technical solutions to enable biopharmaceutical R&D, manufacturing, process, lab, clinical, engineering and business professionals to confront work challenges.
BioPharm International is the longest-running peer-reviewed publication serving an audited global audience of 29,245 BPA-qualified professionals involved in the development and manufacturing of therapeutics and management of related business issues. With the largest US readership in the biopharmaceutical market, BioPharm reaches a large universe of leading biotech and pharmaceutical companies, giving solution providers direct access to the core purchasing power of the biopharmaceutical industry.
 BioSpectrum Asia is a unique, integrated B2B media platform of print, digital, online and events. It engages its readers from Life-Sciences industry (Pharma, Biotech & Medtech) across Asia pacific region on a Daily/Fortnightly/Monthly through its media products and services. BioSpectrum Asia started, as first Business life-science industry magazine with an objective to create a platform for growing Asia-pacific life sciences industry and is today the largest distributed Pan-Asia Life-Sciences industry magazine. The magazine is published, printed and distributed from Singapore by Cyber Media (Singapore) Pte Limited.
About Print magazine
Print edition is distributed monthly across Asia-pacific region covering pharma, biotech and medtech featuring News, articles, interviews, policies, products, events and issues impacting the industry in the regions.
About Digital magazine
Digital magazine is crisp, online, and easy to use, new age media which picks up an issue, segment or country every fortnightly covering the impact it has on the Asia Pacific life-sciences industry. It is delivered on 10th and the 26th of every month subscribers’ desktop to read it online or download for reading it at their convenience
About Portal
www.biospectrumasia.com is a portal updated daily providing rich content for life sciences industry in Asia Pacific region. Easy navigation by country (Key countries in Asia Pacific region) and by sector (Pharma, Biotech and Medical devices) makes it interesting for the readers to get on to relevant information quickly.
ChinaBio® Accelerator is a non-profit organization created to accelerate the globalization of China's biotechnology industry by providing funding, mentoring and connecting early stage China life science companies to investors and partners in the U.S. If you are an early stage China biotech seeking funding or U.S. partnerships, or a U.S.-based organization looking to establish partnerships or operations in China, please contact us to find out how we can help. www.ChinaBioLLC.com
ChinaBio® Today - a new publication covering the China biotech industry. It focuses exclusively on the rapidly evolving biotech industry in China. From its offices in Shanghai and California, ChinaBio® Today provides daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market. www.ChinaBioToday.com
 Now in its 26th year, GEN retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D. Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide. GEN's unique news editorial mandate is the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. GEN is the only publication with this mandate, covering the entirety of commercial bioscience: biopharmaceuticals, bio-agriculture, chemicals and enzymes, and environmental markets, and emerging biosciences including biodefense, bioenergy, and nanobiotechnology. GEN has from the beginning fused industry, academia and government, to foster industry collaborations and agreements
Outsourcing-Pharma.com is the only free online news source covering the full spectrum of contract services to the pharmaceutical and biotechnology industries, from contract research and development through to manufacturing and commercial services.
Offshoring strategies, the rise of contact services in Asia and other emerging markets, product safety, ethical considerations in running clinical trials, issues surrounding animal testing, adaptive trial design and eclinical, the rise of contract sales – Outsourcing-Pharma.com routinely covers all this and more in greater depth than any other online news service.
 PharmaAsia is the leading source of information dedicated to keeping pharmaceutical scientists in Asia looking to stay abreast of innovative technologies and local market dynamics through insightful news, data, feature articles and trends impacting the pharmaceutical industry. Published bi-monthly, with a target of 10,000* qualified readers, the publication provides timely and useful insights into cutting-edge techniques and practices for improving the pace of pharmaceutical research and development in the region. It features in-depth articles on technologies and research relevant to the industry, news and market trends, new product offerings, listings of regional events and profiles of relevant companies and service providers. For more information, please visit us at www.PharmaAsia.com.
*Publisher's own data as of September 2006
Whether you require data for benchmarking, competition analysis or simply to find out what new intellectual properties are being licensed, PharmaDeals® gives you access to the latest deal making information in the pharmaceutical and biotech field. Intelligently indexed, the new PharmaDeals v2 database is the ultimate benchmarking tool. To be the first to request a demonstration, visit www.pharmadeals.net
 Tens of thousands of pharmaceutical professionals worldwide subscribe to Scrip World Pharmaceutical News. Why? Because no other news service covers all aspects of pharma, from biotech developments to M&A activities, in such a succinct, straightforward way. Scrip’s unique mix of well-written stories, from journalists based around the world, makes it essential to anyone working in any sector of the global biopharmaceutical industry.
If you are yet to subscribe to Scrip you should know that no other news service offers such complete industry coverage. No other news service provides its coverage in such a digestible style. And no other news service has provided such indispensable information to your industry for over thirty years.
Scrip remains the most respected source of biopharmaceutical industry news. Find out why: email scripnews@informa.com, quoting code JSN0114S to request a free 5-day trial.
|
